Portfolio company
Tetragenetics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company produces recombinant transmembrane proteins and antibodies for biotechnology firms and academic researchers to enable drug discovery against difficult human disease targets.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Abilita Therapeutics
This biotechnology company develops membrane protein stabilization technologies and antibody therapeutics for pharmaceutical and biotechnology partners targeting challenging drug targets.
Talisman Therapeutics
The company develops human stem cell models of neurodegenerative diseases to provide drug discovery and target validation services for biotechnology and pharmaceutical organisations.
Ciphergen Biosystems
The company develops protein chips and proteomics analysis tools for pharmaceutical firms, biotechnology companies, and research institutions.
Genset
This biotechnology company develops genomics and pharmacogenomics services for pharmaceutical and research customers to identify genes associated with diseases.
Zephyrus Biosciences
This company develops single-cell protein analysis instruments and research tools for academic, biopharmaceutical and clinical scientists conducting disease research.
Tectonic Therapeutic
This biotechnology firm develops protein and antibody therapies targeting G-protein coupled receptors to treat patients with pulmonary hypertension and genetic bleeding disorders.
Glyphic Biotechnologies
This company develops a single-molecule protein sequencing platform for researchers and institutions focused on biological research and drug discovery.
DC Biosciences
DC Biosciences provides proteomics services and research tools to pharmaceutical and biotechnology companies to support drug discovery and development processes.
